![]() |
市場調查報告書
商品編碼
1483114
全球藥物管理系統市場 2024-2031Global Medication Management System Market 2024-2031 |
藥物管理系統市場規模、佔有率和趨勢分析報告(依產品類型分類)(電腦化醫師訂單輸入、臨床決策支援系統解決方案、電子藥物管理記錄、庫存管理解決方案等)。按交付模式(基於 Web、雲端和本地端)。以及最終用戶(藥局和零售藥局、醫院和診所)。預測期(2024-2031)。
預計在預測期內(2024-2031年),藥物管理系統市場將以 12.4%的年複合成長率顯著成長。全球藥物管理系統市場是由用藥錯誤增加、老年人口增加和慢性病負擔增加等因素所推動的。這些因素推動了藥物管理系統的採用,以實現配藥、給藥和監控流程的自動化,減少藥物不良事件,最佳化老年患者的治療,並提高患者的治療效果。電子健康記錄、人工智慧和機器人等技術進步推動了這些系統的創新。遵守 HIPAA 和 EU MDR 等監管要求可確保藥品安全和管理。優先考慮病人安全和護理品質推動了這些系統的採用。醫療保健數位化和互通性促進了這些系統與其他醫療保健 IT 平台的整合。成本控制壓力和患者賦權也促進了市場的成長。
Medication Management System Market Size, Share & Trends Analysis Report by Product Type (Computerized Physician Order Entry, Clinical Decision Support System Solutions, Electronic Medication Administration Record, Inventory Management Solutions, and Others). by Mode of Delivery (Web-based, Cloud-based, and On-premise). and by End-User (Pharmacies and Retail Drug Outlets, and Hospitals and Clinics). Forecast Period (2024-2031).
Medication management system market is anticipated to grow at a significant CAGR of 12.4% during the forecast period (2024-2031). The global medication management system market is driven by factors such as increasing medication errors, growing geriatric populations, and rising chronic disease burden. These factors drive the adoption of medication management systems to automate dispensing, administration, and monitoring processes, reduce adverse drug events, optimize treatment for elderly patients, and enhance patient outcomes. Technological advancements such as electronic health records, AI, and robotics drive innovation in these systems. Compliance with regulatory requirements, such as HIPAA and EU MDR, ensures medication safety and management. Prioritizing patient safety and quality of care drives the adoption of these systems. Healthcare digitalization and interoperability promote the integration of these systems with other healthcare IT platforms. Cost containment pressures and patient empowerment also contribute to the growth of the market.
Market Dynamics
Growing Number of Prescriptions and Expenditure on Medications
The rising global prescription volume and medicine spending underscore the need for efficient medication management systems to streamline workflows, enhance safety, and optimize medication utilization, ultimately improving patient outcomes. According to the IQVIA, in 2020, there were a total of 6.3 billion prescriptions dispensed, showing a modest growth rate of 1.7% after accounting for the use of 90-day prescriptions for chronic therapies. Additionally, US medicine spending experienced a slight increase of 0.8% on a net price basis, reaching $359.0 billion. This increase highlights the widening gap between list or invoice prices and manufacturer net revenues.
Technological Advancements In Healthcare Technology
The continuous progress in healthcare technology, including EHRs, clinical decision support systems, and telemedicine platforms is fueling the development of advanced medication management solutions that offer improved features and seamless integration to drive market growth. According to the World Health Organization (WHO), in September 2023, in the healthcare industry, patient injury is a major problem that influences 10.0% of patients and results in over 3 million fatalities each year from improper treatment. Even greater rates are seen in low- to middle-income nations, where 4 out of every 100 deaths are attributed to subpar care. More than half of cases are preventable, with drugs being the primary cause. Patient damage is frequently caused by adverse events, including drug errors, dangerous surgical procedures, and infections linked to healthcare. Better results and significant cost savings can result from investing in measures to lessen injuries to patients, such as patient engagement.
Market Segmentation
Clinical Decision Support System Solutions is Projected to Emerge as the Largest Segment
Based on the product type, the global medication management system market is sub-segmented into computerized physician order entry, clinical decision support system solutions, electronic medication administration records, inventory management solutions, and others. Among these, the clinical decision support system solutions sub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes AI and ML advancements are driving the development of AI-powered CDSS solutions, enabling the analysis of large datasets to generate personalized treatment recommendations and clinical insights. For instance, in February 2024, Elsevier Health launched ClinicalKey AI, a clinical decision support tool that combines trusted medical content with artificial intelligence to assist clinicians at the point of care. The solution offers high-quality curated content and constantly refreshed evidence-based research, ensuring optimal patient experiences in clinics and hospitals. ClinicalKey AI was developed in collaboration with Cone Health and the University of New Mexico and has been used by over 30,000 physicians across the US.
Cloud-based Sub-segment to Hold a Considerable Market Share
The increasing demand for data-driven insights and personalized medicine is driving the adoption of cloud-based platforms for detailed analysis of health-related data for medication management. For instance, in March 2023, Fujitsu introduced a cloud-based platform that securely collects and uses health-related data for digital transformation in the medical field. The platform conforms to the HL7 FHIR framework and enables detailed analysis in medical practice, clinical research, and drug development, with potential applications in individualized healthcare.
The global medication management system market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Growth of the Pharmaceutical Industry In the Aisa-Pacific Region
The demand for medication management systems, such as pharmacy automation, inventory management, and prescription management software, has been boosted by the rise of the pharmaceutical business in India. These systems are needed to streamline procedures in healthcare institutions. According to the Economic Times, in January 2024, In the fiscal year of 2023, India's pharmaceutical imports accounted for a significant amount of $7.9 billion. The majority of these imports, approximately 85.0% to 90.0%, were comprised of bulk drugs (55.0%) and pharmaceutical formulations (30.0% to 35.0%).
Global Medication Management System Market Growth by Region 2024-2031
Source: OMR Analysis
North America Holds Major Market Share
The global medication management system market is expanding owing to the growing demand for safe, effective solutions for home healthcare, providing patients with convenient, user-friendly tools for injectable medication management. For instance, in March 2022, Hamilton Beach Brands and HealthBeacon developed the Smart Sharps Bin, a digital health tool for managing injectable medications at home. The device offers intelligent reminders, tracking adherence, 24/7 customer care, and safe disposal of used syringes through the US Postal Service's mail-back program.
Note: Major Players Sorted in No Particular Order.
The major companies serving the global medication management system market include Cerner Corp., Epic Systems Corp., GE HealthCare Technologies Inc., McKesson Corp., and Omnicell, Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive. For instance, in March 2021, BD acquired GSL Solutions to improve inventory management, regulatory compliance, and patient safety in retail pharmacies, addressing market consolidation, increasing prescriptions, and changing controlled substance regulations.